SP

Supraja Pandi

Active Director Director DIN 11109860
DIN 11109860 First appointment May 2025 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value •••• Premium profile

About Supraja Pandi

Data last updated:

Supraja Pandi is a Director at Medyrex E-Pharm Private Limited (since 2025). The company operates in Healthcare. Medyrex E-Pharm Private Limited reported revenue of ₹13.2 Lakh (FY 2025).

DIN 11109860
Primary Designation Director
Industry Healthcare
First Appointment 16 May 2025
Oldest Company Age 4 yrs
Largest company Medyrex E-Pharm Private Limited · ₹13.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medyrex E-Pharm Private Limited U85100TG2021PTC157597
Director16 May 20252021₹13.2 Lakh (FY 2025)Active

Board colleagues of Supraja Pandi

NameDINCompanyDesignation
Shanti Tunk10073726Medyrex E-Pharm Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medyrex E-Pharm Private Limited
Premium access

Shareholding and investment profile for Supraja Pandi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Supraja Pandi

Supraja Pandi currently holds 1 directorship: Medyrex E-Pharm Private Limited (Director, since 16 May 2025, revenue ₹13.2 Lakh (FY 2025)).

Supraja Pandi was first appointed on 16 May 2025 as Director at Medyrex E-Pharm Private Limited.

The current boards of Supraja Pandi's companies include Shanti Tunk (Medyrex E-Pharm Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available